I was nauseous constantly
Whereas Wegovy is the higher-dose version authorised for weight loss
The pattern held up fairly consistently regardless of a patients age, sex, race, weight, or which specific GLP-1 drug they took, though researchers noted some of those breakdowns relied on smaller numbers and should be read cautiously
Despite their effectiveness, GLP-1 therapies are not without limitations
AI Ruined Graduation (and Other Things We Need to Talk About, Like Ethan's Weight) AI botched a graduation ceremony in Arizona, mispronouncing and skipping names while students walked the stage and the same concern is sparking student protests right here in Utah
(Exenatide is FDA approved as monotherapy for the management of T2DM.) Explicitly stated in the guideline for patients requiring dual or triple therapy, the AACE/ACE preferentially recommends the addition of a GLP-1 receptor agonist or a DPP-4 inhibitor (sitagliptin, saxagliptin), citing their efficacy and safety profiles as preferred agents over TZDs or sulfonylureas (SUs)
